Hussain Al-Abadi
Free University of Berlin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hussain Al-Abadi.
The Journal of Urology | 1992
Hussain Al-Abadi; Reinhard Nagel
In 72 patients with urothelial carcinoma of the renal pelvis or ureter the ploidy, deoxyribonucleic acid (DNA) heterogeneity and counts of cell cycle phases in the tumor were analyzed by means of single cell DNA cytophotometry with the intention of finding new prognostic factors in addition to those already known (stage and grade). Followup ranged from 1 to 8 years. The results of the DNA analyses were related to the tumor categories, histopathological grading of the tumors and clinical course. Malignancy grade 1 tumors showed DNA frequency peaks in the diploid range, while tumors assessed as malignancy grade 2 showed heterogeneous DNA distribution patterns. Malignancy grade 3 tumors exhibited 71% aneuploid and 29% tetraploid DNA values. The proliferation rate of the tumor cells was statistically significantly higher in malignancy grades 2 and 3 than in malignancy grade 1. The prognosis for grade 1 tumors is good, whereas it is unfavorable in the case of grade 3 tumors. For these 2 groups (patients with grades 1 and 3 tumors) DNA ploidy affords no additional prognostic information. Grade 2 tumors, on the other hand, are heterogeneous in respect to DNA ploidy although they exhibit the same histomorphological degree of differentiation. These tumors can be subclassified as aneuploid (biologically aggressive) and diploid or tetraploid (biologically less aggressive) tumors. There was also a positive correlation between T category and DNA ploidy. The cell lines were aneuploid in 38% of the patients with stage T1 tumors, 56% with stage T2 tumors and almost 85% with stage T3, N+ tumors. A significant correlation was found between the results of DNA cytophotometry and the clinical course of the disease. Patients with diploid tumor cell nuclei had no metastases and no local tumor progression for up to 8 years, whereas patients with aneuploid tumor cell nuclei suffered metastasis and local tumor progression within 24 to 36 months. The patients died of the tumor 36 months after primary diagnosis on the average. The determination of DNA ploidy, tumor heterogeneity and tumor cell proliferation by means of DNA cytophotometry affords valuable clues as to prognosis.
The Journal of Urology | 1994
Hussain Al-Abadi; Reinhard Nagel
In 127 patients with urothelial carcinoma of the bladder the ploidy, deoxyribonucleic acid (DNA) heterogeneity and counts of cell cycle phases in the tumor were analyzed by means of single cell DNA cytophotometry with the intention of finding new prognostic factors in addition to those already known (stage and grade). Patients were followed for 1 to 9 years. The results of the DNA analyses were related to the tumor categories, histopathological grading of the tumor and clinical course. Tumors were histologically classified as grade 1--DNA frequency peaks in the diploid range, grade 2--heterogenous DNA distribution patterns, and grade 3-73% aneuploid and 27% tetraploid DNA values. The proliferation rate of the tumor cells was statistically greater in cases of histological grades 2 and 3 malignancy than in grade 1 malignancy. There was also a positive correlation between tumor stage and DNA ploidy. The cell lines were aneuploid in 38% of the patients with stage pT1, 64% with stage pT2 and almost 85% with stage pT3 tumors. A significant correlation was found between the results of DNA cytophotometry and the clinical course of the disease. Patients with diploid tumor cell lines had no metastases and no local tumor progression for up to 9 years, whereas patients with multiple aneuploid tumor cell lines suffered recurrence and local tumor progression within 6 to 36 months. On the average, the patients died of the tumors 26 months after primary diagnosis. The difference in tumor recurrence and in tumor progression between patients with aneuploid and diploid tumors was highly significant (p < 0.001). The prognosis for patients with grade 1 tumors is good, whereas it is unfavorable in the case of grade 3 tumors. For these 2 groups DNA ploidy affords no additional prognostic information. Grade 2 tumors, on the other hand, are heterogeneous in respect to DNA ploidy, although they exhibit the same degree of histomorphological differentiation. These tumors can be subclassified as aneuploid (biologically aggressive) and diploid or tetraploid (biologically less aggressive). In terms of multivariate Cox regression analysis, DNA ploidy compared with grade and tumor stage was the strongest predictor of survival.
European Journal of Gastroenterology & Hepatology | 2008
Ioannis S. Papanikolaou; Andreas Adler; Katharina Wegener; Hussain Al-Abadi; Angelika Dürr; Martin Koch; Heiko Pohl; Hassan Abou-Rebyeh; Wilfried Veltzke-Schlieker; Bertram Wiedenmann; Thomas Rösch
Objectives Endoscopic ultrasonography (EUS) with the adjunct of EUS-guided fine needle aspiration has become an important diagnostic modality in gastroenterologic oncology. EUS-guided fine needle aspiration mainly relies on cytology; data are scarce that compare cytology and histology. While testing a 22-gauge prototype needle, we prospectively compared the yield for both. Methods Forty-two consecutive patients (27 male, 15 female; mean age 59.2 years, range: 17–90 years) were included. In each patient we aimed to make two needle passes, and if the material acquired appeared insufficient macroscopically (no in-room cytopathology was available), further passes were done. The material was sent for cytological and histological assessment. Results A median number of two passes (range: 2–3) were uneventfully performed for pancreatic lesions (n=30), mediastinal and other lymph nodes/masses (n=8) and various other lesions (n=4) and yielded adequate material for cytology, histology or at least one of the two investigations in 62, 67 and 74% of patients, respectively. No false positive results were found (specificity 100%). Sensitivities were 58.6 and 65.5%, respectively, for cytology and histology alone; combined assessment increased sensitivity to 79.3%. When adjusted values were calculated, based only on those cases with adequate material, sensitivity was 89.5% for cytology and 85.7% for histology, and increased to 100% with combined assessment. Conclusion The new needle achieves sensitivities similar to those previously reported with no significant differences in sensitivity between cytology and histology. More effective tissue acquisition methods must be sought to improve overall results.
Archive | 1994
Hussain Al-Abadi; Reinhard Nagel
In 72 patients with urothelial carcinoma of the renal pelvis or ureter the ploidy and counts of cell cycle phases in the tumor were analyzed by means of single cell DNA cytophotometry with the intention of finding new prognostic factors in addition to those already known (stage and grade). Follow-up ranged from 1 to 10 years. The results of the DNA analyses were related to the tumor categories, histopathological grading and clinical course. Malignancy grade 1 tumors showed DNA frequency peaks in the diploid range, while tumors assessed as malignancy grade 2 showed heterogeneous DNA distribution patterns. Malignancy grade 3 tumors exhibited 71% aneuploid and 29% tetraploid DNA values.
World Journal of Gastroenterology | 2006
A. Spinelli; Guido Schumacher; Andreas Pascher; Enrique Lopez-Hänninen; Hussain Al-Abadi; Christoph Benckert; Igor M. Sauer; Johann Pratschke; Ulf P. Neumann; Sven Jonas; Jan M. Langrehr; Peter Neuhaus
Cancer Detection and Prevention | 1998
Hussain Al-Abadi; Reinhard Nagel; Peter Neuhaus
Gastrointestinal Endoscopy | 2007
Ioannis S. Papanikolaou; Andreas Adler; Katharina Wegener; Martin Koch; Hussain Al-Abadi; Wilfried Veltzke-Schlieker; Heiko Pohl; Ahmed C. Khalifa; Hassan Abou-Rebyeh; Gabriela Geissler; B. Wiedenmann; Thomas Roesch
Gastrointestinal Endoscopy | 2006
Hassan Abou-Rebyeh; Hussain Al-Abadi; Zeynep Al-Khalili; Wilfried Veltzke-Schlieker; Andreas Adler; Nicco Krezdorn; T. Berg; Sven Jonas; Peter Neuhaus; Bertram Wiedenmannn; Thomas Roesch
Gastroenterology | 2001
Hassan Abou-Rebyeh; Hussain Al-Abadi; Sven Jonas; Inga Rotter; Wilfried Veltzke-Schlieker; Andreas Adler; Rainer Eckhard Hintze; Bertram Wiedenmann; Peter Neuhaus
Gastroenterology | 2000
Hussain Al-Abadi; Hassan Abou-Rebyeh; Rainer Eckhard Hintze; Sven Jonas; Wolf O. Bechstein; Peter Neuhaus